« NEW CLINICAL TRIAL OPEN | Main | Updated Melanoma Patient Web Resources & Links 1.19.09 »

2009 AJCC/UICC Melanoma Staging System

I just returned from the International Conference on melanoma held in Vienna. Here's the latest on the AJCC/UICC Staging System to be released in 2009. You might want to check out the Website on Individualized Melanoma Patient Outcome Prediction Tools developed by Seng-jaw Soong et al, referenced below. It's pretty cool!

The major change in the 2009 AJCC/UICC Melanoma Staging System is the inclusion of mitotic activity in the primary as important prognostic factor. Mitotic activity is histologically defined as mitoses/mm2. A mitotic rate equal of greater than 1/mm2 denotes a melanoma at higher risk for metastasis. A test version of a program to determine the 5- and 10- year survival for an individual patient is available on the following Website: www.melanomaprognosis.org. For patients with localized melanoma (Stage I/II melanoma), the significant prognostic factors were found to be gender, age, lesion site, tumor thickness, and ulceration and these are included in the predictive model. For patients with regional metastasis (Stage III melanoma), the significant factors were the same, with the added factors of tumor burden and number of nodes involved with melanoma. The Website allows one to insert these significant prognostic factors for an individual patient and it will use these factors to report estimated 5- and 10- year survival rates and confidence intervals.

Lynn Spitler

Posted on Saturday, May 23, 2009 at 12:14PM by Registered CommenterDr Lynn Spitler | Comments1 Comment

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments (1)

I have just read Dr. Wang's book on Beating Melanoma -- The Survival Manual. I acquired from www.beatingmelanoma.com. It was well written. He talked about the use of dermoscopy and total body photography to detect skin cancer. Does those technology work?

June 11, 2009 | Unregistered CommenterSam

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>